Picture of Biomea Fusion logo

BMEA Biomea Fusion Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Annual cashflow statement for Biomea Fusion, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUS10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-1.2-5.32-41.6-81.8-117
Depreciation
Non-Cash Items00.4467.4511.116.8
Other Non-Cash Items
Changes in Working Capital-0.0810.411-1.577.672.33
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities-1.28-4.46-35.4-62.4-96.6
Capital Expenditures0-0.051-3.17-1.03-3.37
Purchase of Fixed Assets
Other Investing Cash Flow Items-30.228.41.15
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities0-0.051-33.427.3-2.22
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1.44661531.24164
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.16161.584.4-33.865